3//SEC Filing
Frazier Life Sciences IX, L.P. 3
Accession 0001209191-19-042486
CIK 0001759425other
Filed
Jul 16, 8:00 PM ET
Accepted
Jul 17, 5:48 PM ET
Size
10.2 KB
Accession
0001209191-19-042486
Insider Transaction Report
Form 3
FHMLS IX, L.L.C.
10% Owner
Holdings
Series A Preferred Stock
→ Common Stock (3,116,912 underlying)
Topper James N
10% Owner
Holdings
Series A Preferred Stock
→ Common Stock (3,116,912 underlying)
Frazier Life Sciences IX, L.P.
10% Owner
Holdings
Series A Preferred Stock
→ Common Stock (3,116,912 underlying)
FHMLS IX, L.P.
10% Owner
Holdings
Series A Preferred Stock
→ Common Stock (3,116,912 underlying)
Footnotes (3)
- [F1]The shares of Series A Preferred Stock have no expiration date and are convertible at any time at the election of the holder without payment of further consideration. Each share of Series A Preferred Stock will automatically convert into 0.125 shares of Common Stock upon the closing of the Issuer's initial public offering.
- [F2]Share numbers give effect to the reverse split of each share of the Issuer's Common Stock into 0.125 shares of Common Stock effected on July 3, 2019, which will be effective for the Preferred Stock upon its conversion to Common Stock upon the closing of the Issuer's initial public offering.
- [F3]The shares are held directly by Frazier Life Sciences IX, L.P. FHMLS IX, L.P. is the general partner of Frazier Life Sciences IX, L.P. FHMLS IX, L.L.C. is the general partner of FHMLS IX, L.P. James N. Topper and Patrick Heron are the managing members of FHMLS IX, L.L.C. and share voting and dispositive power over the shares held by Frazier Life Sciences IX, L.P. Mr. Topper, FHMLS IX, L.P. and FHMLS IX, L.L.C. disclaim beneficial ownership of the shares held by Frazier Life Sciences IX, L.P., except to the extent of his or its pecuniary interest therein, if any.
Documents
Issuer
Mirum Pharmaceuticals, Inc.
CIK 0001759425
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001720320
Filing Metadata
- Form type
- 3
- Filed
- Jul 16, 8:00 PM ET
- Accepted
- Jul 17, 5:48 PM ET
- Size
- 10.2 KB